Serial 90508314
Dead / Abandoned — Abandoned — no statement of use filed (as of 24 Jun 2024)
What this means for you
This application is over — abandoned 24 Jun 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90508314
- Mark type
- Design / logo
- Filed
- 03 Feb 2021
- Published for opposition
- 28 Sept 2021
- Abandoned
- 24 Jun 2024
- Attorney of record
- R. Gwen Peterson
Goods and services
- Class 001 — Chemicals: Diagnostic preparations for clinical use and scientific research; biological tissue cultures for clinical use and scientific research; antibodies for clinical use and scientific research; combinations of biological tissue cultures for clinical use and scientific research; and combinations of antibodies for clinical use and scientific research
- Class 005 — Pharmaceuticals: Biologics for medical use, namely, biological preparations for the treatment or prophylaxis of cancer; biologics for medical use, namely, biological preparations for the treatment or prophylaxis of infectious diseases; pharmaceutical preparations, biologics and antibodies for the treatment of oncological, infectious disease, and immune system related diseases, disorders and conditions; diagnostic agents, preparations and substances for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations, biologics and antibodies for medical purposes, namely, for detecting the presence of malignant, inflammatory, infectious and autoimmune diseases, disorders and conditions in humans
- Class 042 — Scientific and technological services: Biological and pharmaceutical research and development; research, design and development of diagnostics for predicting the response of patients to therapeutics; research, design and development of biologics; research, design and development of combinations of such diagnostics and biologics; molecular biology research for diagnostic preparations, biologics, combinations of diagnostic preparations and biologics, and diagnostic kits for scientific research use; scientific research in the field of cancer and infectious disease treatment and diagnosis; providing laboratory research services in the field of cancer biology and infectious disease biology; testing, inspection, research and development of pharmaceutical preparations for cancer and infectious diseases; providing laboratory research services in the field of cancer biology and infectious diseases; research and development services in the field of antibodies; providing medical and scientific research information in the fields of cancer research, infectious disease research and disease classification; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- Atreca, Inc., San Carlos, CA, US
- Atreca, Inc., San Carlos, CA, US
Prosecution history
- 12 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 24 Jun 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 07 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Oct 2023 — SOU EXTENSION 4 GRANTED
- 05 Oct 2023 — SOU EXTENSION 4 FILED
- 05 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 05 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 May 2023 — SOU EXTENSION 3 GRANTED
- 03 May 2023 — SOU EXTENSION 3 FILED
- 03 May 2023 — SOU TEAS EXTENSION RECEIVED
- 05 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Oct 2022 — SOU EXTENSION 2 GRANTED
- 03 Oct 2022 — SOU EXTENSION 2 FILED
- 03 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 13 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED